Epic FDA Thursday, July 16, 2020 0.00 Neutral

FDA Approves OXYCODONE AND ASPIRIN — Epic Pharma, LLC

Epic Pharma, LLC received FDA approval for its ANDA040910 on July 16, 2020, to manufacture and market generic oxycodone and aspirin in oral tablets. This approval expands the manufacturer’s portfolio, further intensifying North American generic competition for this combination analgesic.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed